Author: Vinayak Joshi

  1. Market News
Lupin Ltd’s stock fell 6% on Friday after the company reported a 64.72% Y-o-Y slump in its consolidated net profit to ₹106.9 crores for the quarter ended June. In the year-ago period, net profit stood at ₹303.05 crores. Lupin is one of the largest generic pharmaceutical companies by revenue globally. The company’s key focus areas include paediatrics, cardiovascular, anti-infectives, […]